A Study of INS365 Ophthalmic Solution in Patients With Moderate to Severe Dry Eye Disease

NCT00679718 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2015-08-27

No results posted yet for this study

Summary

To evaluate the efficacy and safety of INS365 Ophthalmic Solution when applied topically in patients with moderate to severe dry eye disease.

Conditions

Interventions

DRUG

diquafosol tetrasodium (INS365) ophthalmic solution

Sponsors & Collaborators

Principal Investigators

  • Clinical Director · Merck Sharp & Dohme LLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-01-31
Primary Completion
2000-07-31
Completion
2000-07-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00679718 on ClinicalTrials.gov